Navigation Links
Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results
Date:8/10/2009

fees paid to BTG and expenses related to manufacturing development of KRYSTEXXA decreased by $2.0 million each, as the majority of our research and development activities associated with the development of KRYSTEXXA were incurred in prior years. Partially offsetting the decreases in research and development expenses were higher costs of $1.8 million associated with the production of commercial batches of pegloticase API by BTG and $0.9 million in consulting expenses related to our preparation for the FDA Arthritis Advisory Committee meeting held on June 16, 2009.

Selling, general and administrative expenses for first six months of 2009 were $16.9 million, compared with $19.7 million for the same period of 2008, a decrease of $2.8 million. The decrease was primarily due to lower legal fees of $2.9 million as the prior year results reflect expenses for Oxandrin-related patent infringement litigation and $2.0 million of lower compensation and benefits, including share-based compensation, due primarily to decreased headcount and share-based awards. Partially offsetting the lower expenses are higher pre-launch marketing expenses of $1.1 million incurred in preparation for a potential commercial launch of KRYSTEXXA.

Investment income, net, decreased $1.6 million to an expense of $0.2 million for the first six months of 2009, from income of $1.4 million for the same period of 2008. The decrease was primarily attributable to lower dividend and interest income from lower cash, cash equivalent and investment balances.

Other expense, net, increased $35.9 million primarily as a result of a non-cash charge relating to the mark-to-market valuation adjustment to our warrant liability during the first six months of 2009.

Our income tax benefit decreased $2.8 million to zero for the first six months of 2009, as we no longer have the ability to carry back losses to previous years to recover taxes paid
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Savient Pharmaceuticals to Present at the Credit Suisse Phoenix Healthcare Conference on November 13th
2. Savients Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
3. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
4. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
5. Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
6. Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Zereana Jess-Huff, a 34-year-old mother, corporate executive ... a platform to think outside the bra. She doesn’t try ... to raise awareness about women’s other lady parts. , "We ... say the color pink and everybody knows what you’re talking ... that it has not been won when it comes to ...
(Date:10/20/2014)... Principle Business Enterprises, a family owned company for ... products. The company has recently made efforts to ... Premium Protection absorbent products. The company has redesigned ... a new look, and is currently working on innovative ... , The new website, developed with Thread Marketing Group ...
(Date:10/20/2014)... October 20, 2014 Rockynol Retirement ... Center on Oct. 14. The $11 million project will ... and a cooked-to-order kitchen with full-service restaurant style dining. ... choice for first class Assisted Living apartments,” said Kara ... deserve the highest quality of care and this investment ...
(Date:10/20/2014)... Columbus, OH (PRWEB) October 20, 2014 National ... Ohio Chapter of the American Academy of Pediatrics (Ohio AAP, ... Administration (NHTSA) in encouraging parents of teen drivers to talk ... hit the road. , Motor vehicle crashes are the leading ... 2,055 teen drivers involved in fatal crashes, and 859 (42%) ...
(Date:10/20/2014)... DALLAS (PRWEB) October 20, 2014 It’s hard ... for many orphans and vulnerable children around the world, it’s ... by some people, many children are forced to walk barefoot ... for their families or play with their friends. , ... partnering with Air1 Radio in October to encourage ...
Breaking Medicine News(10 mins):Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3
... Haikerwal, said today that the Federal Budget must be more ... fairness, fitness, and equity of access to quality health ... that the Governments reported generosity with tax cuts must be ... ,Fixing Indigenous health has to be the priority ...
... of Idahos trout population and a loss of $40,000, ... outbreak of Ichthyophthirius multifilis has killed around 250,000 trout from ... and Game hatchery, in Nampa. This is the second such ... resulted when stress from overcrowding weakened the fish, making them ...
... of the cells that help build the body's supply of ... embryonic stem cells, and have been produced in substantial ... lab animal treatment of diabetes, heart disease and wounds.,A team ... Mass., reported the creation of these precursor cells, known as ...
... company Advanced Cell Technology, is obviously thrilled with ... repair arteries and regenerate blood. , According to ... proceed on to hearts and arteries of ... have devised a straightforward way to make blood vessel precursor ...
... over the century from 972 in 1901 to 927 in 1991. ... In contrast, the child sex ratio for the age group of ... recorded in 1991 Census. As far as worldwide sex ratio is ... of the reasons commonly put forward to explain the consistently low levels ...
... Lara has thrown a punch at the West Indies Cricket ... named after him. ,He commended the persons and ... Lara Cancer Center for their "teamwork, integrity and use of ... Cricket Board. ,His statement underlines the fact there ...
Cached Medicine News:Health News:Health Budget Must Focus On Access To Medical Services, Fitness And Nutrition 2Health News:Disease Outbreak Claims Trout From Idaho Hatchery 2Health News:Hemangioblasts Aiding Eye Damage Repair 2
(Date:10/19/2014)... 2014 CTI BioPharma Corp. (CTI) (NASDAQ and ... third quarter 2014 financial results on Wednesday, October 29, ... Following the announcement, members of the management team will ... and provide a general corporate update at 4:30 p.m. ... be obtained as follows: Wednesday, October 29 ...
(Date:10/17/2014)... Oct. 17, 2014  Training market researchers to ... success factor in today,s highly competitive global marketplace. ... organizations that effectively and efficiently produce high performing ... area. Effective training programs can ... recognition from internal clients by developing analysts who ...
(Date:10/17/2014)... DUBLIN , Oct. 17, 2014 ... of the "Research and Development Prospect of ... offering. Based on the 2013 ... Chinese government policies about dialysis industry and the ... in-depth research about dialysis industry segmentations. Moreover, it ...
Breaking Medicine Technology:CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2Effective Training Programs for Market Research Groups can Boost Overall Organizational Success 2Research and Development Prospect of China Dialysis Market, 2014-2018 2Research and Development Prospect of China Dialysis Market, 2014-2018 3
... /PRNewswire-Asia/ -- Global Pharm Holdings Group, Inc. ... a China-based, growing vertically integrated pharmaceutical company ... Medicine ("TCM") herbs cultivation and processing business ... and Shandong provinces, today announced that it ...
... Oct. 26, 2011 AtheroNova Inc. (OTCBB: AHRO), a ... compounds to regress atherosclerotic plaque, today announced that it ... the U.S. Food and Drug Administration (FDA). During the ... of AHRO-001, AtheroNova,s lead patent-pending compound for the prevention ...
Cached Medicine Technology:Global Pharm Announces the Closing of US$15 Million Redeemable Convertible Bonds Financing 2Global Pharm Announces the Closing of US$15 Million Redeemable Convertible Bonds Financing 3AtheroNova Completes Successful Pre-IND Meeting with FDA on AHRO-001 2AtheroNova Completes Successful Pre-IND Meeting with FDA on AHRO-001 3
A distal femoral nail providing high purchase in osteoporotic metaphyseal bone and two distal locking options: one spiral blade plus one locking screw or two locking screws....
... to information on the Internet is finally ... enabling you to interact with your PC ... Voice Information Retrieval Software, you can ask ... topics and receive up-to-date information from the ...
... non-invasive and painless method of stimulating the ... manufactures two magnetic stimulation devices, the MES-10 ... The Hight Speed MES-10 magnetic ... to 25 Hz at full power. ...
... monitor ever made, with all the capabilities you'll ... weight and a third the size of any ... everything you need for cardiac resuscitation: fast, easy ... monitoring, built-in AC or DC power, and an ...
Medicine Products: